Full results from a second Phase 3 clinical study of LMTX®, the first tau aggregation inhibitor in Alzheimer’s disease, has been released by researchers.
from Top Health News – ScienceDaily http://ift.tt/2jv9jYJ
from Tumblr http://ift.tt/2ilJe1K
Full results from a second Phase 3 clinical study of LMTX®, the first tau aggregation inhibitor in Alzheimer’s disease, has been released by researchers.
No comments:
Post a Comment